Register to our new webinar dedicated to our bioactive ingredient, Pep2Dia®, for glucose and weight management!
GLP-1–based therapies have transformed our understanding of metabolic health, demonstrating the importance of hormonal regulation, appetite, glucose control, and postprandial physiology.
At the same time, their benefits and limitations have raised interest in alternative and complementary approaches.
The success of GLP-1 therapies has also brought new attention to the physiological mechanisms that regulate metabolic health.
This webinar will explore how this perspective is moving us beyond fasting glucose and HbA1c toward a more dynamic understanding of how the body responds to and recovers from each meal.
We will introduce the emerging concept of postprandial resilience and explore how Pep2Dia® fits into this evolving perspective.
Join us on October 20th to learn more about:
- Our solution: Pep2Dia®
- GLP-1
- Postprandial resilience
This presentation is intended to marketing, R&D and purchase managers.
With our expert speakers Julie Auger, Eléa Witrant from Ingredia and Dr. Marc Dellière:
Julie Auger
Scientific & Regulatory Specialist - Ingredia
Eléa Witrant
Brand Manager - Ingredia
Dr. Marc Dellière
Medical Consultant & Trainer